From network destabilisation to adaptive reconfiguration: A hippocampal longitudinal axis model of psychedelic therapy.
Charalampos L. Kandilakis, Costas Papatheodoropoulos
Progress in Neuro-Psychopharmacology and Biological Psychiatry August 20, 2026 DOI: 10.1016/j.pnpbp.2026.111898 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Longitudinal Peer reviewed |
|---|---|
| Topics | Neuroplasticity Psychedelic-assisted therapy |
| Keywords | Critical-period plasticity Excitation/inhibition balance Hippocampal longitudinal axis Interneurons Network dynamics Psychedelics Psychiatric disorders Hippocampus |
| Key points | Proposes that psychedelic-assisted therapy works through a dual-phase process: acute E/I destabilization (Phase I) followed by experience-dependent plasticity and re-stabilization (Phase II), with the hippocampal longitudinal axis providing a spatially organized substrate for transdiagnostic therapeutic effects. |
Abstract
Psychedelic-assisted therapy has emerged as a promising therapeutic approach across several psychiatric disorders, yet the mechanisms linking acute brain-state changes and subjective experience to sustained clinical improvement remain incompletely understood. Here, we extend a previously proposed excitation/inhibition (E/I)-centred dual-phase model of psychedelic action to the therapeutic context and develop the hippocampal longitudinal axis as a circuit-level framework for its spatially differentiated effects. In Phase I, psychedelics induce a transient destabilisation of E/I dynamics, increasing neural flexibility and altering network organisation while loosening maladaptive activity patterns that may contribute to the acute psychedelic experience. In Phase II, activity- and experience-dependent plasticity processes promote adaptive reorganisation and re-stabilisation of neural circuits. We further hypothesise that the anterior-posterior hippocampal axis provides a spatially organised substrate through which regionally differentiated E/I dynamics may contribute to transdiagnostic therapeutic effects across affective, cognitive, and behavioural symptom domains, and help explain differential symptom responses across patients. This framework links acute network destabilisation to sustained circuit reconfiguration, providing a spatially resolved account of psychedelic-assisted therapeutic change and generating experimentally testable predictions regarding candidate biomarkers (e.g., E/I-related neuroimaging measures and hippocampal connectivity profiles), treatment response, and risk.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Proposes that psychedelic-assisted therapy works through a dual-phase process: acute E/I destabilization followed by experience-dependent plasticity and re-stabilization, with the hippocampal longitudinal axis providing a spatially organized substrate for transdiagnostic therapeutic effects.
Synthesized
Comparable studies
Other theoretical and historical papers on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders. | 2024 | Theoretical or philosophical paper | |
| Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance | 2020 | Theoretical or philosophical paper | |
| Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy | 2018 | Theoretical or philosophical paper | |
| Ethical and legal issues in psychedelic harm reduction and integration therapy | 2021 | Theoretical or philosophical paper | |
| Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. | 2022 | Theoretical or philosophical paper |
Citations in the library
Cites 38
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 33 more in the library